Article
Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.
Cancer research - 1 Mar 2014
Gomez German G, Volinia Stefano, Croce Carlo M, Zanca Ciro, Li Ming, Emnett Ryan, Gutmann David H, Brennan Cameron W, Furnari Frank B, Cavenee Webster K
Abstract excerpt
The EGF receptor (EGFR) is amplified and mutated in glioblastoma, in which its common mutation (ΔEGFR, also called EGFRvIII) has a variety of activities that promote growth and inhibit death, thereby conferring a strong tumor-enhancing effect. This range of activities suggested to us that ΔEGFR m...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
